熱門資訊> 正文
Indaptus Therapeutics将执行1比28反向股票分割
2025-06-25 19:57
- Indaptus Therapeutics (NASDAQ:INDP) has approved a 1-for-28 reverse stock split of its common stock, effective after trading closes on June 26, 2025.
- The stock split is intended to increase the per share price and bid price of the company’s common stock to regain compliance with the continued listing requirements of Nasdaq.
- The number of authorized shares of the company’s common stock will not change, while the number of outstanding shares will be reduced from approximately 16M to approximately 572 thousand.
- INDP -30.5% premarket.
More on Indaptus Therapeutics
- Indaptus Therapeutics announces sale of $2.3M of convertible notes, warrants
- Indaptus Therapeutics GAAP EPS of -$0.32 misses by $0.14
- Seeking Alpha’s Quant Rating on Indaptus Therapeutics
- Historical earnings data for Indaptus Therapeutics
- Financial information for Indaptus Therapeutics
推薦文章
美股機會日報 | 特朗普放大招！9萬億養老金即將殺入加密市場；美聯儲主席候選人支持7月降息
一周財經日曆 | 特斯拉、谷歌財報重磅來襲！維立志博將於下周五登陸港交所
一圖看懂 | 港股上半年IPO募資額登頂全球！中籤就賺一萬港幣的「大肉籤」你參與了嗎？
華盛早報丨重大突破！三大加密貨幣法案眾議院闖關成功；美聯儲，降息大消息
黃仁勛年內三度訪華！H20重返中國市場，釋放了什麼信號？
創新葯行情徹底爆發！維立志博-B打新半日孖展超購130倍，凍資近150億港元
新股申購 | 維立志博-B入場費3535.30港元！引入騰訊、易方達等基石投資者
7月財報預告丨迎關税考驗！特斯拉、臺積電放榜在即，美股能否守住漲勢？
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
